What's Happening?
Neko Health, a body-scanning and health assessment startup founded by Spotify's Daniel Ek and Hjalmar Nilsonne, has raised $700 million in a Series C funding round. The round was led by Lightspeed Venture Partners and O.G. Venture Partners, following
a $260 million Series B in January 2025. Neko Health's technology combines body scans with bloodwork and Apple Health data to provide comprehensive health assessments. The company plans to open its first U.S. location in New York, with over 100,000 scans already conducted and 350,000 people on the waitlist.
Why It's Important?
The significant investment in Neko Health underscores the growing interest in health technology and personalized medicine. By expanding its operations to the U.S., Neko Health aims to tap into a larger market and offer its innovative health assessment services to more people. The company's technology has already proven beneficial, as evidenced by Calm founder Alex Tew's experience, where a scan detected a malignant mole. This expansion could lead to increased competition in the health tech sector, particularly in the area of body-scanning technologies.
